You are here: Industry Insights > CTA

News List

CASI Pharmaceuticals Announces Submission Of Clinical Trial Application (IND) To Conduct Phase 1 Study For Anti-38 Monoclonal Antibody Program prnewswire
June 09, 2020
CASI Pharmaceuticals, Inc. announced that it submitted a Clinical Trial Application (CTA) (IND) with the United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) for CID-103.
Gilead files lawsuit against US federal government over alleged contract breaches europeanpharmaceuticalreview
May 05, 2020
Gilead’s complaint alleges five contract breaches by the US Centers for Disease Control and Prevention (CDC) and seeks a declaration of contract breach and damages.
BioMarin Submits CTA in UK for Investigational Gene Therapy for PKU americanpharmaceuticalreview
September 27, 2019
BioMarin Pharmaceutical has submitted a Clinical Trial Application (CTA) with the Medicines and Healthcare Products Regulatory Agency (MHRA) in the U.K. for BMN 307 ...
Calculated Tumor Area Has Prognostic Value for Melanoma drugs
July 02, 2019
Calculated Tumor Area Has Prognostic Value for Melanoma.
China National Medical Products Administration Approves Sinovant's Clinical Trial Application for Derazantinib prnewswire
April 29, 2019
Sinovant Sciences today announced that its Clinical Trial Application (CTA) for derazantinib has been accepted by the Center for Drug Evaluation at the China National Medical Products Administration (NMPA)